Identification of circulating biomarkers of Crohn's disease and spondyloarthritis using Fourier transform infrared spectroscopy
© 2022 The Authors. Journal of Biophotonics published by Wiley-VCH GmbH..
Crohn's disease (CD) and spondyloarthritis (SpA) are two inflammatory diseases sharing many common features (genetic polymorphism, armamentarium). Both diseases lack diagnostic markers of certainty. While the diagnosis of CD is made by a combination of clinical, and biological criteria, the diagnosis of SpA may take several years to be confirmed. Based on the hypothesis that CD and SpA alter the biochemical profile of plasma, the objective of this study was to evaluate the analytical capability of Fourier transform infrared spectroscopy (FTIR) in identifying spectral biomarkers. Plasma from 104 patients was analyzed. After data processing of the spectra by Extended Multiplicative Signal Correction and linear discriminant analysis, we demonstrated that it was possible to distinguish CD and SpA from controls with an accuracy of 97% and 85% respectively. Spectral differences were mainly associated with proteins and lipids. This study showed that FTIR analysis is efficient to identify plasma biosignatures specific to CD or SpA.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
|---|---|
| Enthalten in: |
Journal of biophotonics - 16(2023), 2 vom: 12. Feb., Seite e202200200 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Prada, Pierre [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Biomarkers |
|---|
| Anmerkungen: |
Date Completed 08.02.2023 Date Revised 15.02.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/jbio.202200200 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346293561 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346293561 | ||
| 003 | DE-627 | ||
| 005 | 20231226031100.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jbio.202200200 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1154.xml |
| 035 | |a (DE-627)NLM346293561 | ||
| 035 | |a (NLM)36112612 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Prada, Pierre |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Identification of circulating biomarkers of Crohn's disease and spondyloarthritis using Fourier transform infrared spectroscopy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 08.02.2023 | ||
| 500 | |a Date Revised 15.02.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 The Authors. Journal of Biophotonics published by Wiley-VCH GmbH. | ||
| 520 | |a Crohn's disease (CD) and spondyloarthritis (SpA) are two inflammatory diseases sharing many common features (genetic polymorphism, armamentarium). Both diseases lack diagnostic markers of certainty. While the diagnosis of CD is made by a combination of clinical, and biological criteria, the diagnosis of SpA may take several years to be confirmed. Based on the hypothesis that CD and SpA alter the biochemical profile of plasma, the objective of this study was to evaluate the analytical capability of Fourier transform infrared spectroscopy (FTIR) in identifying spectral biomarkers. Plasma from 104 patients was analyzed. After data processing of the spectra by Extended Multiplicative Signal Correction and linear discriminant analysis, we demonstrated that it was possible to distinguish CD and SpA from controls with an accuracy of 97% and 85% respectively. Spectral differences were mainly associated with proteins and lipids. This study showed that FTIR analysis is efficient to identify plasma biosignatures specific to CD or SpA | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Crohn's disease | |
| 650 | 4 | |a Fourier transform infrared | |
| 650 | 4 | |a biomarkers | |
| 650 | 4 | |a chemometrics | |
| 650 | 4 | |a diagnostic | |
| 650 | 4 | |a plasma | |
| 650 | 4 | |a spectroscopy | |
| 650 | 4 | |a spondyloarthritis | |
| 650 | 7 | |a Biomarkers |2 NLM | |
| 700 | 1 | |a Brunel, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Moulin, David |e verfasserin |4 aut | |
| 700 | 1 | |a Rouillon, Lise |e verfasserin |4 aut | |
| 700 | 1 | |a Netter, Patrick |e verfasserin |4 aut | |
| 700 | 1 | |a Loeuille, Damien |e verfasserin |4 aut | |
| 700 | 1 | |a Slimano, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Bouche, Olivier |e verfasserin |4 aut | |
| 700 | 1 | |a Peyrin-Biroulet, Laurent |e verfasserin |4 aut | |
| 700 | 1 | |a Jouzeau, Jean-Yves |e verfasserin |4 aut | |
| 700 | 1 | |a Piot, Olivier |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of biophotonics |d 2008 |g 16(2023), 2 vom: 12. Feb., Seite e202200200 |w (DE-627)NLM187619646 |x 1864-0648 |7 nnns |
| 773 | 1 | 8 | |g volume:16 |g year:2023 |g number:2 |g day:12 |g month:02 |g pages:e202200200 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/jbio.202200200 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 16 |j 2023 |e 2 |b 12 |c 02 |h e202200200 | ||